Get the Stockscreener App
0.0008
27.27%
-0.0003
Propanc Biopharma Inc Stock (PPCB) Forecast
The Propanc Biopharma Inc (PPCB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.00652, representing a +715.25% increase from the current price of $0.0008. The highest analyst price target is $0.00683, and the lowest is $0.00622.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PPCB Price Target
Average 0.00689
(+761.16% Upside)
Long-term PPCB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Propanc Biopharma Inc financial reports and earnings history, Propanc Biopharma Inc (PPCB) stock could reach $0.0281 by 2030, $0.0937 by 2040 and $0.0562 by 2050. See the projected annual prices until 2050 of the Propanc Biopharma Inc stock below:
- Propanc Biopharma Inc (PPCB) is expected to reach an average price of $0.0506 in 2035, with a high prediction of $0.0596 and a low estimate of $0.0508. This indicates an $6,225% rise from the last recorded price of $0.0008.
- Propanc Biopharma Inc (PPCB) stock is projected to chart a bullish course in 2040, with an average price target of $0.082, representing an $10,144% surge from its current level. The forecast ranges from a conservative $0.0822 to a sky-high $0.0937.
- Our analysts predict Propanc Biopharma Inc (PPCB) to jump 14,708% by 2045, soaring from $0.0288 to an average price of $0.1185, potentially reaching $0.1246. While $0.0288 is the low estimate, the potential upside is significant.
- Propanc Biopharma Inc (PPCB) stock is expected to climb by 2050, reaching an average of $0.0458, a $5,630% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.0562 and $0.0355, respectively, highlighting the market's uncertainty.
Propanc Biopharma Inc Stock (PPCB) Year by Year Forecast
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2024
Our forecast for PPCB stock price in 2024 now indicates an average price target of $0.00535 with a high forecast of $0.00936 and a low forecast of $0.00133. The average prediction reflects an increase of +568.45% from the last recorded price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.00582 | $0.00622 | $0.00683 | +627.16% |
| July, 2024 | $0.00514 | $0.00534 | $0.00561 | +542.99% |
| August, 2024 | $0.00408 | $0.00413 | $0.00479 | +409.41% |
| September, 2024 | $0.00255 | $0.00255 | $0.00327 | +218.99% |
| October, 2024 | $0.01 | $0.00194 | $0.00921 | +1,151% |
| November, 2024 | $0.00913 | $0.00933 | $0.00936 | +1,042% |
| December, 2024 | $0.00762 | $0.00772 | $0.00849 | +852.08% |
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2025
Propanc Biopharma Inc Stock (PPCB) is expected to reach an average price of $0.00844 in 2025, with a high prediction of $0.0143 and a low estimate of $0.00255. This indicates an +955.16% rise from the last recorded price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.00614 | $0.00624 | $0.00697 | +667.91% |
| February, 2025 | $0.00447 | $0.00467 | $0.0056 | +458.74% |
| March, 2025 | $0.00329 | $0.00255 | $0.00403 | +311.23% |
| April, 2025 | $0.0121 | $0.0121 | $0.0118 | +1,413% |
| May, 2025 | $0.00988 | $0.0103 | $0.0114 | +1,134% |
| June, 2025 | $0.00832 | $0.00852 | $0.00931 | +939.49% |
| July, 2025 | $0.00654 | $0.00659 | $0.00778 | +717.23% |
| August, 2025 | $0.00456 | $0.00476 | $0.00556 | +469.98% |
| September, 2025 | $0.0151 | $0.00316 | $0.0143 | +1,791% |
| October, 2025 | $0.0135 | $0.0137 | $0.0143 | +1,593% |
| November, 2025 | $0.0116 | $0.0117 | $0.0127 | +1,345% |
| December, 2025 | $0.00896 | $0.00906 | $0.0107 | +1,020% |
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2026
The predicted value for Propanc Biopharma Inc (PPCB) in 2026 is set at an average of $0.0116. Estimates vary from a peak of $0.0195 to a trough of $0.00377, indicating an +1,352% surge from the present price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.00658 | $0.00678 | $0.00824 | +722.23% |
| February, 2026 | $0.0043 | $0.0044 | $0.00596 | +436.89% |
| March, 2026 | $0.0169 | $0.00377 | $0.0169 | +2,009% |
| April, 2026 | $0.0139 | $0.0143 | $0.016 | +1,642% |
| May, 2026 | $0.0122 | $0.0125 | $0.013 | +1,425% |
| June, 2026 | $0.009 | $0.00905 | $0.0113 | +1,025% |
| July, 2026 | $0.00631 | $0.00651 | $0.00784 | +689.14% |
| August, 2026 | $0.0203 | $0.00439 | $0.0195 | +2,431% |
| September, 2026 | $0.018 | $0.0182 | $0.0193 | +2,145% |
| October, 2026 | $0.0153 | $0.0154 | $0.017 | +1,808% |
| November, 2026 | $0.0118 | $0.0119 | $0.0143 | +1,372% |
| December, 2026 | $0.00869 | $0.00889 | $0.0109 | +985.72% |
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Propanc Biopharma Inc (PPCB) is $0.0148, with a high forecast of $0.0246 and a low forecast of $0.005. This indicates an +1,748% increase from the last price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.00569 | $0.00579 | $0.00789 | +611.72% |
| February, 2027 | $0.022 | $0.005 | $0.022 | +2,653% |
| March, 2027 | $0.018 | $0.0184 | $0.0209 | +2,149% |
| April, 2027 | $0.0155 | $0.0158 | $0.0167 | +1,843% |
| May, 2027 | $0.0115 | $0.0115 | $0.0145 | +1,333% |
| June, 2027 | $0.00807 | $0.00827 | $0.0101 | +908.30% |
| July, 2027 | $0.0259 | $0.00561 | $0.0239 | +3,131% |
| August, 2027 | $0.0224 | $0.0226 | $0.0246 | +2,697% |
| September, 2027 | $0.019 | $0.0191 | $0.0212 | +2,271% |
| October, 2027 | $0.0155 | $0.0157 | $0.0178 | +1,834% |
| November, 2027 | $0.0108 | $0.011 | $0.0145 | +1,249% |
| December, 2027 | $0.00709 | $0.00719 | $0.00982 | +786.55% |
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2028
In 2028, Propanc Biopharma Inc (PPCB) is projected to reach an average price of $0.0192, with a high projection of $0.0323 and a low estimate of $0.00622. This indicates an +2,305% rise from the last price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0264 | $0.00622 | $0.0271 | +3,201% |
| February, 2028 | $0.0221 | $0.0225 | $0.0251 | +2,656% |
| March, 2028 | $0.0189 | $0.0192 | $0.0204 | +2,262% |
| April, 2028 | $0.0148 | $0.015 | $0.0176 | +1,755% |
| May, 2028 | $0.00982 | $0.01 | $0.0138 | +1,127% |
| June, 2028 | $0.0312 | $0.00683 | $0.0292 | +3,794% |
| July, 2028 | $0.0268 | $0.027 | $0.0297 | +3,248% |
| August, 2028 | $0.0227 | $0.0228 | $0.0254 | +2,734% |
| September, 2028 | $0.0185 | $0.0187 | $0.0213 | +2,208% |
| October, 2028 | $0.0129 | $0.0131 | $0.0173 | +1,513% |
| November, 2028 | $0.00849 | $0.00859 | $0.0117 | +961.37% |
| December, 2028 | $0.0319 | $0.00744 | $0.0323 | +3,890% |
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2029
The 2029 price forecast for Propanc Biopharma Inc Stock (PPCB) is $0.0227 on average, with a high prediction of $0.0374 and a low estimate of $0.00805. This represents an +2,739% increase from the previous price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0261 | $0.0265 | $0.0305 | +3,164% |
| February, 2029 | $0.0222 | $0.0225 | $0.0242 | +2,681% |
| March, 2029 | $0.0175 | $0.0177 | $0.0208 | +2,085% |
| April, 2029 | $0.0116 | $0.0118 | $0.0162 | +1,347% |
| May, 2029 | $0.0365 | $0.00805 | $0.0345 | +4,456% |
| June, 2029 | $0.0323 | $0.0326 | $0.0348 | +3,941% |
| July, 2029 | $0.0264 | $0.0265 | $0.0311 | +3,197% |
| August, 2029 | $0.0215 | $0.0217 | $0.0248 | +2,582% |
| September, 2029 | $0.016 | $0.0165 | $0.0201 | +1,905% |
| October, 2029 | $0.00989 | $0.00999 | $0.0146 | +1,136% |
| November, 2029 | $0.0369 | $0.00866 | $0.0374 | +4,508% |
| December, 2029 | $0.0302 | $0.0306 | $0.0352 | +3,671% |
Propanc Biopharma Inc Stock (PPCB) Price Forecast for 2030
Propanc Biopharma Inc Stock (PPCB) is expected to reach an average price of $0.0259 in 2030, with a high forecast of $0.0425 and a low forecast of $0.00927. This signifies an +3,136% surge from the last price of $0.0008.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0256 | $0.0259 | $0.0281 | +3,099% |
| February, 2030 | $0.0201 | $0.0203 | $0.024 | +2,415% |
| March, 2030 | $0.0148 | $0.0149 | $0.0187 | +1,756% |
| April, 2030 | $0.0418 | $0.00927 | $0.0398 | +5,119% |
| May, 2030 | $0.0369 | $0.0372 | $0.0399 | +4,515% |
| June, 2030 | $0.0312 | $0.0314 | $0.0355 | +3,799% |
| July, 2030 | $0.0245 | $0.0247 | $0.0297 | +2,957% |
| August, 2030 | $0.0183 | $0.0188 | $0.0229 | +2,191% |
| September, 2030 | $0.0113 | $0.0114 | $0.0167 | +1,311% |
| October, 2030 | $0.0418 | $0.00988 | $0.0425 | +5,126% |
| November, 2030 | $0.0361 | $0.0364 | $0.04 | +4,415% |
| December, 2030 | $0.0289 | $0.0292 | $0.0319 | +3,518% |
2.56%
9.61%
Cap:
|
Volume (24h):